Main Pages
Articles for $MAIA
MAIA Biotechnology Approves Significant Bonuses for CEO and Head of Finance Following Capital RaiseMAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung CancerMAIA Biotechnology, Inc. Files 8-K for Regulation FD Disclosure on March 27, 2026